XWELL (XWEL) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
1 Apr, 2026Company overview and business model
Operates as a global wellness organization with three segments: XpresSpa (airport spa services), XpresTest (bio-surveillance and testing), and Naples Wax Center (hair removal and skincare).
Expanded internationally with spa locations in the UAE, Netherlands, and Turkey, and is pursuing further international growth.
Transitioned from COVID-19 testing to bio-surveillance in partnership with the CDC, securing multi-year contracts.
Acquired Naples Wax Center to diversify beyond airport-based services and scale the wellness platform.
Financial performance and metrics
XpresTest secured a three-year CDC contract with a base value of $22.2 million and a maximum of $24.8 million.
Naples Wax Center was acquired for $1.624 million to support long-term financial goals.
Use of proceeds and capital allocation
Will not receive proceeds from resale of shares by selling stockholders; proceeds from warrant exercises, if any, will be used for general corporate purposes.
Latest events from XWELL
- Q2 2026 saw revenue down 7% YoY, a narrowed loss, and a $13M airport business sale announced.XWEL
Q2 2026 - Shareholders are to vote on a $13M divestiture, with proceeds retained for strategic use.XWEL
Proxy filing - $6.6M revenue, $11.2M net loss, and $28.3M raised to improve liquidity and simplify capital structure.XWEL
Q1 2026 - 2025 revenue hit $29.2M, with cost reductions and new capital fueling expansion and innovation.XWEL
Q4 2025 - Board recommends approval of all annual meeting proposals, including reverse split and share issuance.XWEL
Proxy Filing - Annual meeting to vote on directors, auditor, executive pay, and tax asset protection plan.XWEL
Proxy Filing - Board recommends voting for all proposals, including director elections and tax asset protection.XWEL
Proxy Filing - Stockholders to vote on equity issuance, board structure, plan amendments, and auditor ratification.XWEL
Proxy Filing - Registering 1,051,677 shares for resale may cause significant dilution to existing stockholders.XWEL
Registration Filing